MucoLife Therapeutics
MucoLife Therapeutics is a Swedish biotech company developing mucus-targeting therapies to treat airway obstruction in patients with chronic obstructive pulmonary disease (COPD) and cystic fibrosis.
MucoLife Therapeutics has raised €91k across 1 funding round from 1 investor, most recently a round in Nov 2026. Based in Gothenburg, Sweden; active in Healthtech. Data as of Nov 2026.
Gothenburg, Swedenmucolife.com ↗
Total raised
€91k
€90,695
Funding rounds
1
Investors
1
distinct backers
Active since
2026-11
latest 2026-11
Funding by year
EUR raised per year · 2026 YTDMucoLife Therapeutics — funding by year — interactive chart.
Data table
| MucoLife Therapeutics — funding by year | |
|---|---|
| 2026 | €91k |
Signals
High confidenceRaise-next likelihood10
base rate 30% for Other
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-11-06 | Other | €91k | Vinnova | View deal → |
Investors
1Related news
Similar companies
same sector, similar size- Amra Medical—Sweden · Healthtech
- Wellbefy€112kSweden · Healthtech
- Vevios€122kSweden · Healthtech
- Deversify€125kSweden · Healthtech
- Dropmed—Sweden · Healthtech
- Evolving Therapeutics€100kSpain · Healthtech
Global coverage: FundingData